ELAN
Elanco Animal Health Incorporated
Drug Manufacturers - Specialty & Generic · Healthcare · United States
22.51
close · 2026-08-13
value
48
cheaper than peers48
quality
56
stronger fundamentals56
ranked against
Drug Manufacturers - Specialty & Generic
value
quality
34 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 1.71× | 74 |
| price to sales | 2.41× | 56 |
| EV to EBITDA | 16.83× | 40 |
| forward P/E | 17.81× | 31 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 66.2% | 64 |
| revenue growth | 10.2% | 61 |
| operating margin | 8.6% | 54 |
| return on equity | -3.8% | 38 |
4 of 4 measures available
Facts
| market cap | $11B |
| free cash flow | $692.1M |
| employees | 9,400 |
| first trade | 2018-09-20 |
| next earnings | 2026-08-05 |
| fundamentals updated | 2026-08-06 |